The Effects of Apple Consumption on Cardiovascular Health in Prediabetics and Type 2 Diabetics
Regular Apple Consumption Improves Cardiovascular Risk Factors and Glycemic Control in Overweight and Obese Prediabetics and Type 2 Diabetics
2 other identifiers
interventional
50
1 country
1
Brief Summary
The hypothesis of this study is that the daily consumption of 75 g dried apple powder for twelve weeks will improve arterial stiffness and blood pressure by improving endothelial-mediated vasodilation and vascular sympathetic activity and favorably altering biochemical markers associated with cardiovascular risk and glycemic control compared to a macronutrient-matched control powder. 50 men and women between the ages of 45 and 65 with prediabetes or type 2 diabetes who are overweight or obese will be included in the study. After a two-week run-in phase, eligible men and women will be randomly assigned to one of two treatment groups: 1) 75 g dried apple powder; or 2) 75 g placebo powder daily for twelve weeks. After an initial telephone screening, all participants will be requested to report to the study site for their first visit. On the first visit (screening), participants will be provided with verbal and written explanation of the project. They will then be asked to sign an informed consent form, followed by measuring fasting glucose levels and a medical history questionnaire to confirm prediabetes or type 2 diabetes. Baseline assessments will be performed for medical history, medication use, dietary intake, and physical activity. Qualified participants will be scheduled for their second visit two weeks later (actual baseline data collection) and randomly assigned to their treatment group. On the second (baseline) visit between the hours of 6:00-11:00 A.M., blood pressure and vascular function will be measured followed by blood draw and urine collection. Anthropometrics will be measured. Participants will be provided with their assigned treatment and will receive standard instructions on how to fill out daily diaries for their treatment, and for food and physical activity records. Blood pressure, vascular function, blood draw, urine collection, and anthropometric, body composition, diet, and physical activity assessments will be repeated at 6- (third visit), and 12-week (final visit) intervals. All cardiovascular measurements will be performed between 6:00 to 11:00 A.M., in a quiet temperature-controlled room in the supine position after an overnight fast and 12 hours after the abstinence of caffeine and/or 24 hours after the last bout of moderate to heavy physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 diabetes
Started Aug 2014
Typical duration for phase_2 diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 21, 2014
CompletedFirst Posted
Study publicly available on registry
August 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 8, 2016
December 1, 2016
2.3 years
August 21, 2014
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure
By measuring brachial and aortic blood pressure at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).
12 weeks
Secondary Outcomes (8)
Arterial Stiffness
12 weeks
Autonomic Control of Blood Pressure
12 weeks
Endothelial-mediated Vasodilation
12 weeks
Inflammation
12 weeks
Oxidative Stress
12 weeks
- +3 more secondary outcomes
Study Arms (2)
Apple
EXPERIMENTAL12 weeks of 75 g dried apple powder taken in 480 ml per day.
Placebo
PLACEBO COMPARATOR12 weeks of 75 g apple-flavored placebo powder taken in 480 ml per day.
Interventions
Eligibility Criteria
You may qualify if:
- Men and women (1 to 10 years postmenopausal)
- Aged 45-65 years
- Prediabetes or Type 2 Diabetes (Hemoglobin A1c ≥ 5.7%)
- Overweight or obese (body mass index between 25 and 40 kg/m2)
You may not qualify if:
- Diagnosed cardiovascular disease
- Uncontrolled hypertension (≥ 160/100 mmHg)
- Other active chronic diseases such as cancer, asthma, glaucoma, thyroid, kidney, liver and pancreatic disease
- Participating in a weight loss program
- Heavy smokers (\> 20 cigarettes per day)
- Heavy drinkers (\> 12 alcoholic drinks per week)
- Consumption of more than two apples per week
- Body mass index less than 25 or greater than 40 kg/m2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- U.S. Apple Associationcollaborator
Study Sites (1)
Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University
Tallahassee, Florida, 32306, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bahram H. Arjmandi, PhD, RD
Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University
- PRINCIPAL INVESTIGATOR
Arturo Figueroa, MD, PhD
Department of Nutrition, Food and Exercise Sciences, Florida State University
- PRINCIPAL INVESTIGATOR
Sarah A. Johnson, PhD, RDN
Department of Food Science and Human Nutrition, Colorado State University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Margaret A. Sitton Professor
Study Record Dates
First Submitted
August 21, 2014
First Posted
August 25, 2014
Study Start
August 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
December 8, 2016
Record last verified: 2016-12